Haemonetics Corp - Company Profile
Powered by 
All the sales intelligence you need on Haemonetics Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Haemonetics Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Haemonetics Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Haemonetics Corporation (Haemonetics) is a global medical technology company focused on enhancing healthcare quality, effectiveness, and efficiency. The company specialises in developing innovative solutions for hospital technologies, plasma collection, and blood component collection. Haemonetics offers products such as automated plasma collection systems, donor management software, and blood management technologies. Notable brands include NexSys PCS and VASCADE. The company's products serve healthcare providers, plasma centers, and blood centers, addressing critical medical needs across various applications. Haemonetics operates through a network of channel partners and distribution networks to reach its customers. The company targets markets worldwide, with a significant presence in the United States and other regions. Haemonetics is headquartered in Boston, Massachusetts, the US.
Haemonetics Corp premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| - | - | - |
| Plasma | fiber optic sensor solutions | Elite |
| Automated plasma collection devices | Business Consulting | PCS |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In December, the company signed a definitive agreement to sell its whole blood assets to GVS, S.p.A, a manufacturer of filter solutions. |
| 2024 | New Products/Services | In August, the company announced the full market launch of its VASCADE MVP XL mid-bore venous closure system. |
| 2024 | New Products/Services | In June, the company introduced its new VASCADE MVP XL. |
Competitor Comparison
| Key Parameters | Haemonetics Corp | Medtronic Plc | Fresenius SE & Co KGaA | WerfenLife SA | LivaNova Plc |
|---|---|---|---|---|---|
| Headquarters | United States of America | Ireland | Germany | Spain | United Kingdom |
| City | Boston | Dublin | Bad Homburg | Barcelona | London |
| State/Province | Massachusetts | - | Hessen | Barcelona | England |
| No. of Employees | 3,023 | 95,000 | 178,394 | - | 2,900 |
| Entity Type | Public | Public | Public | Private | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Christopher A. Simon | Chief Executive Officer; Director; President | Executive Board | 2016 | 62 |
| James D’Arecca | Executive Vice President; Chief Financial Officer | Senior Management | 2022 | 54 |
| Frank Chan, Ph.D. | Executive Vice President; Chief Operating Officer | Senior Management | 2025 | 55 |
| Jan Hartmann, M.D. | Senior Vice President; Chief Medical Officer | Senior Management | 2023 | - |
| Roy Galvin | Executive Vice President; Chief Commercial Officer | Senior Management | 2025 | 56 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer